[1]
Siegel, L.; Miller, D.; Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin., 2017, 67(1), 7-30.
[2]
McGuire, S. World cancer report 2014 Geneva, Switzerland: world health organization, international agency for research on cancer who press, 2015. Adv. Nutr., 2016, 7(2), 418-419.
[3]
Rivera, M.; Mehta, A.; Wahidi, M. Establishing the diagnosis of lung cancer diagnosis and management of lung cancer; , 2013.
[4]
Bach, P.B.; Jett, J.R.; Pastorino, U. Computed tomography screening and lung cancer outcomes. JAMA, 2007, 297(9), 953-961.
[5]
Wolf, A.; Oeffinger, K.; Shih, T. Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J. Clin., 2024, 74(1), 50-81.
[6]
Gould, M. Personalized lung cancer screening: are we ready to engage? Cancer, 2021, 127(23), 4362-4364.
[7]
Infante, M.; Cardillo, G. Lung cancer screening in never-smokers: facts and remaining issues. Eur. Respir. J., 2020, 56(5), 1-5.
[8]
Bailey, J.; Van Haren, R. Complementary roles of screening and nodule programs for Early Detection of Lung Cancer in Diverse Populations. Ann. Surg. Oncol., 2022, 29(9), 5347-5349.
[9]
Lancaster, H.; Heuvelmans, M.; Oudkerk, M. Low-dose computed tomography lung cancer screening: clinical evidence and implementation research. J. Intern. Med., 2022, 292(1), 68-80.
[10]
Cervera, J.; Barrios, M.; Peñalver, J.C. Lung cancer screening: survival in an extensive early detection program in Spain (I-ELCAP). Arch. Bronconeumol., 2022, 58(5), 406-411.
[11]
Wood, D.; Kazerooni, E.; Aberle, D. NCCN guidelines® Insights: lung cancer screening, version 1.2022. J. Natl. Compr. Canc. Netw., 2022, 20(7), 754-764.
[12]
Nooreldeen, R.; Bach, H. Current and future development in lung cancer diagnosis. Int. J. Mol. Sci., 2021, 22(16), 1-18.
[13]
The Lancet Respiratory Medicine. Feasibility of lung cancer screening in resource-poor areas. Lancet Respir. Med., 2022, 10(4), 313-314.
Related Journals
